Global Seborrheic Dermatitis Treatment

Seborrheic Dermatitis Treatment Comprehensive Study by Type (Antifungal Products, Corticosteroid Lotions, Prescription-Strength Medicated Shampoos, Sulfur Products), Route of Administration (Oral, Topical), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Form Type (Creams, Shampoos, Ointments, Gels, Others) Players and Region - Global Market Outlook to 2026

Seborrheic Dermatitis Treatment Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Seborrheic Dermatitis is an eczema that affects the oil glands in the scalp, nose, and upper back. Hormonal changes or disease, cold, dry weather, stress, harsh detergents, chemicals, and soaps may all cause seborrheic dermatitis. It has itchy reddish or pink patches of skin that are surrounded by greasy scales or flakes. Seborrheic Dermatitis is a common dermatological condition that affects people all over the world. Immuno compromised patients, such as HIV patients, lymphoma patients, and organ transplant recipients, are more likely to develop seborrheic dermatitis. In mild cases, a medicated shampoo or a topical antifungal cream (such as selenium sulphide, ketoconazole, or coal tar) may be sufficient to control symptoms, while in serious cases, a prescription for a mild corticosteroid medication to reduce inflammation may be needed. Recent advancements in eczema care have improved the quality of life for many patients, but a sizable portion of the affected population remains untapped.This growth is primarily driven by Advancements in Seborrheic Dermatitis Products and Treatment Methods, The Growing Global Geriatric Population that are Most Commonly Affected by Seborrheic Dermatitis and Rising Awareness Regarding Personal Care Products.

Globally, a noticeable market trend is evident Organic Products (Shampoos and Conditioners) with no Chemicals. Major Players, such as Sonoma Pharmaceuticals (United States), Merck (United States), Henkel (Germany), Arcutis Biotherapeutics (United States), Unilever (United Kingdom), Hikma Pharmaceuticals (United Kingdom), Allen and Hanburys(United Kingdom), GlaxoSmithKline (United Kingdom), Bausch Health (Canada), Valent Pharmaceutical (United Kingdom) and West-Ward Pharmaceutical Corp. (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

September 2020 – Arcutis Announces Positive Topline Data from Phase 2 Clinical Trial Evaluating ARQ-154 (Topical Roflumilast Foam) as a Potential Treatment for Seborrheic Dermatitis

Market Drivers
  • Advancements in Seborrheic Dermatitis Products and Treatment Methods
  • The Growing Global Geriatric Population that are Most Commonly Affected by Seborrheic Dermatitis
  • Rising Awareness Regarding Personal Care Products

Market Trend
  • Organic Products (Shampoos and Conditioners) with no Chemicals

Restraints
  • High Cost of Products
  • False Claim of Some Local Companies

Opportunities
Increasing Adoption of E-Commerce Marketing Techniques by Manufacturers and Increasing R&D for the Development of New Products for the Treatment of Seborrheic Dermatitis
Challenges
Stringent Regulations for Product Approvals and Several Players Present in the Market

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Seborrheic Dermatitis Treatment Study Sheds Light on
— The Seborrheic Dermatitis Treatment Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Seborrheic Dermatitis Treatment industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Seborrheic Dermatitis Treatment industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Antifungal Products
  • Corticosteroid Lotions
  • Prescription-Strength Medicated Shampoos
  • Sulfur Products
By Route of Administration
  • Oral
  • Topical

By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Form Type
  • Creams
  • Shampoos
  • Ointments
  • Gels
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Advancements in Seborrheic Dermatitis Products and Treatment Methods
      • 3.2.2. The Growing Global Geriatric Population that are Most Commonly Affected by Seborrheic Dermatitis
      • 3.2.3. Rising Awareness Regarding Personal Care Products
    • 3.3. Market Challenges
      • 3.3.1. Stringent Regulations for Product Approvals
      • 3.3.2. Several Players Present in the Market
    • 3.4. Market Trends
      • 3.4.1. Organic Products (Shampoos and Conditioners) with no Chemicals
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Seborrheic Dermatitis Treatment, by Type, Route of Administration, Distribution Channel, Form Type and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Seborrheic Dermatitis Treatment (Value)
      • 5.2.1. Global Seborrheic Dermatitis Treatment by: Type (Value)
        • 5.2.1.1. Antifungal Products
        • 5.2.1.2. Corticosteroid Lotions
        • 5.2.1.3. Prescription-Strength Medicated Shampoos
        • 5.2.1.4. Sulfur Products
      • 5.2.2. Global Seborrheic Dermatitis Treatment by: Route of Administration (Value)
        • 5.2.2.1. Oral
        • 5.2.2.2. Topical
      • 5.2.3. Global Seborrheic Dermatitis Treatment by: Distribution Channel (Value)
        • 5.2.3.1. Hospital Pharmacies
        • 5.2.3.2. Retail Pharmacies
        • 5.2.3.3. Online Pharmacies
      • 5.2.4. Global Seborrheic Dermatitis Treatment by: Form Type (Value)
        • 5.2.4.1. Creams
        • 5.2.4.2. Shampoos
        • 5.2.4.3. Ointments
        • 5.2.4.4. Gels
        • 5.2.4.5. Others
      • 5.2.5. Global Seborrheic Dermatitis Treatment Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Seborrheic Dermatitis Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Sonoma Pharmaceuticals (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Henkel (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Arcutis Biotherapeutics (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Unilever (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Hikma Pharmaceuticals (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Allen and Hanburys(United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. GlaxoSmithKline (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Bausch Health (Canada)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Valent Pharmaceutical (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. West-Ward Pharmaceutical Corp. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Seborrheic Dermatitis Treatment Sale, by Type, Route of Administration, Distribution Channel, Form Type and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Seborrheic Dermatitis Treatment (Value)
      • 7.2.1. Global Seborrheic Dermatitis Treatment by: Type (Value)
        • 7.2.1.1. Antifungal Products
        • 7.2.1.2. Corticosteroid Lotions
        • 7.2.1.3. Prescription-Strength Medicated Shampoos
        • 7.2.1.4. Sulfur Products
      • 7.2.2. Global Seborrheic Dermatitis Treatment by: Route of Administration (Value)
        • 7.2.2.1. Oral
        • 7.2.2.2. Topical
      • 7.2.3. Global Seborrheic Dermatitis Treatment by: Distribution Channel (Value)
        • 7.2.3.1. Hospital Pharmacies
        • 7.2.3.2. Retail Pharmacies
        • 7.2.3.3. Online Pharmacies
      • 7.2.4. Global Seborrheic Dermatitis Treatment by: Form Type (Value)
        • 7.2.4.1. Creams
        • 7.2.4.2. Shampoos
        • 7.2.4.3. Ointments
        • 7.2.4.4. Gels
        • 7.2.4.5. Others
      • 7.2.5. Global Seborrheic Dermatitis Treatment Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Seborrheic Dermatitis Treatment: by Type(USD Million)
  • Table 2. Seborrheic Dermatitis Treatment Antifungal Products , by Region USD Million (2015-2020)
  • Table 3. Seborrheic Dermatitis Treatment Corticosteroid Lotions , by Region USD Million (2015-2020)
  • Table 4. Seborrheic Dermatitis Treatment Prescription-Strength Medicated Shampoos , by Region USD Million (2015-2020)
  • Table 5. Seborrheic Dermatitis Treatment Sulfur Products , by Region USD Million (2015-2020)
  • Table 6. Seborrheic Dermatitis Treatment: by Route of Administration(USD Million)
  • Table 7. Seborrheic Dermatitis Treatment Oral , by Region USD Million (2015-2020)
  • Table 8. Seborrheic Dermatitis Treatment Topical , by Region USD Million (2015-2020)
  • Table 9. Seborrheic Dermatitis Treatment: by Distribution Channel(USD Million)
  • Table 10. Seborrheic Dermatitis Treatment Hospital Pharmacies , by Region USD Million (2015-2020)
  • Table 11. Seborrheic Dermatitis Treatment Retail Pharmacies , by Region USD Million (2015-2020)
  • Table 12. Seborrheic Dermatitis Treatment Online Pharmacies , by Region USD Million (2015-2020)
  • Table 13. Seborrheic Dermatitis Treatment: by Form Type(USD Million)
  • Table 14. Seborrheic Dermatitis Treatment Creams , by Region USD Million (2015-2020)
  • Table 15. Seborrheic Dermatitis Treatment Shampoos , by Region USD Million (2015-2020)
  • Table 16. Seborrheic Dermatitis Treatment Ointments , by Region USD Million (2015-2020)
  • Table 17. Seborrheic Dermatitis Treatment Gels , by Region USD Million (2015-2020)
  • Table 18. Seborrheic Dermatitis Treatment Others , by Region USD Million (2015-2020)
  • Table 19. South America Seborrheic Dermatitis Treatment, by Country USD Million (2015-2020)
  • Table 20. South America Seborrheic Dermatitis Treatment, by Type USD Million (2015-2020)
  • Table 21. South America Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2015-2020)
  • Table 22. South America Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 23. South America Seborrheic Dermatitis Treatment, by Form Type USD Million (2015-2020)
  • Table 24. Brazil Seborrheic Dermatitis Treatment, by Type USD Million (2015-2020)
  • Table 25. Brazil Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2015-2020)
  • Table 26. Brazil Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 27. Brazil Seborrheic Dermatitis Treatment, by Form Type USD Million (2015-2020)
  • Table 28. Argentina Seborrheic Dermatitis Treatment, by Type USD Million (2015-2020)
  • Table 29. Argentina Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2015-2020)
  • Table 30. Argentina Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 31. Argentina Seborrheic Dermatitis Treatment, by Form Type USD Million (2015-2020)
  • Table 32. Rest of South America Seborrheic Dermatitis Treatment, by Type USD Million (2015-2020)
  • Table 33. Rest of South America Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2015-2020)
  • Table 34. Rest of South America Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 35. Rest of South America Seborrheic Dermatitis Treatment, by Form Type USD Million (2015-2020)
  • Table 36. Asia Pacific Seborrheic Dermatitis Treatment, by Country USD Million (2015-2020)
  • Table 37. Asia Pacific Seborrheic Dermatitis Treatment, by Type USD Million (2015-2020)
  • Table 38. Asia Pacific Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2015-2020)
  • Table 39. Asia Pacific Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 40. Asia Pacific Seborrheic Dermatitis Treatment, by Form Type USD Million (2015-2020)
  • Table 41. China Seborrheic Dermatitis Treatment, by Type USD Million (2015-2020)
  • Table 42. China Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2015-2020)
  • Table 43. China Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 44. China Seborrheic Dermatitis Treatment, by Form Type USD Million (2015-2020)
  • Table 45. Japan Seborrheic Dermatitis Treatment, by Type USD Million (2015-2020)
  • Table 46. Japan Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2015-2020)
  • Table 47. Japan Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 48. Japan Seborrheic Dermatitis Treatment, by Form Type USD Million (2015-2020)
  • Table 49. India Seborrheic Dermatitis Treatment, by Type USD Million (2015-2020)
  • Table 50. India Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2015-2020)
  • Table 51. India Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 52. India Seborrheic Dermatitis Treatment, by Form Type USD Million (2015-2020)
  • Table 53. South Korea Seborrheic Dermatitis Treatment, by Type USD Million (2015-2020)
  • Table 54. South Korea Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2015-2020)
  • Table 55. South Korea Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 56. South Korea Seborrheic Dermatitis Treatment, by Form Type USD Million (2015-2020)
  • Table 57. Taiwan Seborrheic Dermatitis Treatment, by Type USD Million (2015-2020)
  • Table 58. Taiwan Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2015-2020)
  • Table 59. Taiwan Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 60. Taiwan Seborrheic Dermatitis Treatment, by Form Type USD Million (2015-2020)
  • Table 61. Australia Seborrheic Dermatitis Treatment, by Type USD Million (2015-2020)
  • Table 62. Australia Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2015-2020)
  • Table 63. Australia Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 64. Australia Seborrheic Dermatitis Treatment, by Form Type USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Seborrheic Dermatitis Treatment, by Type USD Million (2015-2020)
  • Table 66. Rest of Asia-Pacific Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2015-2020)
  • Table 67. Rest of Asia-Pacific Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 68. Rest of Asia-Pacific Seborrheic Dermatitis Treatment, by Form Type USD Million (2015-2020)
  • Table 69. Europe Seborrheic Dermatitis Treatment, by Country USD Million (2015-2020)
  • Table 70. Europe Seborrheic Dermatitis Treatment, by Type USD Million (2015-2020)
  • Table 71. Europe Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2015-2020)
  • Table 72. Europe Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 73. Europe Seborrheic Dermatitis Treatment, by Form Type USD Million (2015-2020)
  • Table 74. Germany Seborrheic Dermatitis Treatment, by Type USD Million (2015-2020)
  • Table 75. Germany Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2015-2020)
  • Table 76. Germany Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 77. Germany Seborrheic Dermatitis Treatment, by Form Type USD Million (2015-2020)
  • Table 78. France Seborrheic Dermatitis Treatment, by Type USD Million (2015-2020)
  • Table 79. France Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2015-2020)
  • Table 80. France Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 81. France Seborrheic Dermatitis Treatment, by Form Type USD Million (2015-2020)
  • Table 82. Italy Seborrheic Dermatitis Treatment, by Type USD Million (2015-2020)
  • Table 83. Italy Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2015-2020)
  • Table 84. Italy Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 85. Italy Seborrheic Dermatitis Treatment, by Form Type USD Million (2015-2020)
  • Table 86. United Kingdom Seborrheic Dermatitis Treatment, by Type USD Million (2015-2020)
  • Table 87. United Kingdom Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2015-2020)
  • Table 88. United Kingdom Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 89. United Kingdom Seborrheic Dermatitis Treatment, by Form Type USD Million (2015-2020)
  • Table 90. Netherlands Seborrheic Dermatitis Treatment, by Type USD Million (2015-2020)
  • Table 91. Netherlands Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2015-2020)
  • Table 92. Netherlands Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 93. Netherlands Seborrheic Dermatitis Treatment, by Form Type USD Million (2015-2020)
  • Table 94. Rest of Europe Seborrheic Dermatitis Treatment, by Type USD Million (2015-2020)
  • Table 95. Rest of Europe Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2015-2020)
  • Table 96. Rest of Europe Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 97. Rest of Europe Seborrheic Dermatitis Treatment, by Form Type USD Million (2015-2020)
  • Table 98. MEA Seborrheic Dermatitis Treatment, by Country USD Million (2015-2020)
  • Table 99. MEA Seborrheic Dermatitis Treatment, by Type USD Million (2015-2020)
  • Table 100. MEA Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2015-2020)
  • Table 101. MEA Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 102. MEA Seborrheic Dermatitis Treatment, by Form Type USD Million (2015-2020)
  • Table 103. Middle East Seborrheic Dermatitis Treatment, by Type USD Million (2015-2020)
  • Table 104. Middle East Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2015-2020)
  • Table 105. Middle East Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 106. Middle East Seborrheic Dermatitis Treatment, by Form Type USD Million (2015-2020)
  • Table 107. Africa Seborrheic Dermatitis Treatment, by Type USD Million (2015-2020)
  • Table 108. Africa Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2015-2020)
  • Table 109. Africa Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 110. Africa Seborrheic Dermatitis Treatment, by Form Type USD Million (2015-2020)
  • Table 111. North America Seborrheic Dermatitis Treatment, by Country USD Million (2015-2020)
  • Table 112. North America Seborrheic Dermatitis Treatment, by Type USD Million (2015-2020)
  • Table 113. North America Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2015-2020)
  • Table 114. North America Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 115. North America Seborrheic Dermatitis Treatment, by Form Type USD Million (2015-2020)
  • Table 116. United States Seborrheic Dermatitis Treatment, by Type USD Million (2015-2020)
  • Table 117. United States Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2015-2020)
  • Table 118. United States Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 119. United States Seborrheic Dermatitis Treatment, by Form Type USD Million (2015-2020)
  • Table 120. Canada Seborrheic Dermatitis Treatment, by Type USD Million (2015-2020)
  • Table 121. Canada Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2015-2020)
  • Table 122. Canada Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 123. Canada Seborrheic Dermatitis Treatment, by Form Type USD Million (2015-2020)
  • Table 124. Mexico Seborrheic Dermatitis Treatment, by Type USD Million (2015-2020)
  • Table 125. Mexico Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2015-2020)
  • Table 126. Mexico Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 127. Mexico Seborrheic Dermatitis Treatment, by Form Type USD Million (2015-2020)
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Seborrheic Dermatitis Treatment: by Type(USD Million)
  • Table 140. Seborrheic Dermatitis Treatment Antifungal Products , by Region USD Million (2021-2026)
  • Table 141. Seborrheic Dermatitis Treatment Corticosteroid Lotions , by Region USD Million (2021-2026)
  • Table 142. Seborrheic Dermatitis Treatment Prescription-Strength Medicated Shampoos , by Region USD Million (2021-2026)
  • Table 143. Seborrheic Dermatitis Treatment Sulfur Products , by Region USD Million (2021-2026)
  • Table 144. Seborrheic Dermatitis Treatment: by Route of Administration(USD Million)
  • Table 145. Seborrheic Dermatitis Treatment Oral , by Region USD Million (2021-2026)
  • Table 146. Seborrheic Dermatitis Treatment Topical , by Region USD Million (2021-2026)
  • Table 147. Seborrheic Dermatitis Treatment: by Distribution Channel(USD Million)
  • Table 148. Seborrheic Dermatitis Treatment Hospital Pharmacies , by Region USD Million (2021-2026)
  • Table 149. Seborrheic Dermatitis Treatment Retail Pharmacies , by Region USD Million (2021-2026)
  • Table 150. Seborrheic Dermatitis Treatment Online Pharmacies , by Region USD Million (2021-2026)
  • Table 151. Seborrheic Dermatitis Treatment: by Form Type(USD Million)
  • Table 152. Seborrheic Dermatitis Treatment Creams , by Region USD Million (2021-2026)
  • Table 153. Seborrheic Dermatitis Treatment Shampoos , by Region USD Million (2021-2026)
  • Table 154. Seborrheic Dermatitis Treatment Ointments , by Region USD Million (2021-2026)
  • Table 155. Seborrheic Dermatitis Treatment Gels , by Region USD Million (2021-2026)
  • Table 156. Seborrheic Dermatitis Treatment Others , by Region USD Million (2021-2026)
  • Table 157. South America Seborrheic Dermatitis Treatment, by Country USD Million (2021-2026)
  • Table 158. South America Seborrheic Dermatitis Treatment, by Type USD Million (2021-2026)
  • Table 159. South America Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2021-2026)
  • Table 160. South America Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 161. South America Seborrheic Dermatitis Treatment, by Form Type USD Million (2021-2026)
  • Table 162. Brazil Seborrheic Dermatitis Treatment, by Type USD Million (2021-2026)
  • Table 163. Brazil Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2021-2026)
  • Table 164. Brazil Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 165. Brazil Seborrheic Dermatitis Treatment, by Form Type USD Million (2021-2026)
  • Table 166. Argentina Seborrheic Dermatitis Treatment, by Type USD Million (2021-2026)
  • Table 167. Argentina Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2021-2026)
  • Table 168. Argentina Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 169. Argentina Seborrheic Dermatitis Treatment, by Form Type USD Million (2021-2026)
  • Table 170. Rest of South America Seborrheic Dermatitis Treatment, by Type USD Million (2021-2026)
  • Table 171. Rest of South America Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2021-2026)
  • Table 172. Rest of South America Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 173. Rest of South America Seborrheic Dermatitis Treatment, by Form Type USD Million (2021-2026)
  • Table 174. Asia Pacific Seborrheic Dermatitis Treatment, by Country USD Million (2021-2026)
  • Table 175. Asia Pacific Seborrheic Dermatitis Treatment, by Type USD Million (2021-2026)
  • Table 176. Asia Pacific Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2021-2026)
  • Table 177. Asia Pacific Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 178. Asia Pacific Seborrheic Dermatitis Treatment, by Form Type USD Million (2021-2026)
  • Table 179. China Seborrheic Dermatitis Treatment, by Type USD Million (2021-2026)
  • Table 180. China Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2021-2026)
  • Table 181. China Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 182. China Seborrheic Dermatitis Treatment, by Form Type USD Million (2021-2026)
  • Table 183. Japan Seborrheic Dermatitis Treatment, by Type USD Million (2021-2026)
  • Table 184. Japan Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2021-2026)
  • Table 185. Japan Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 186. Japan Seborrheic Dermatitis Treatment, by Form Type USD Million (2021-2026)
  • Table 187. India Seborrheic Dermatitis Treatment, by Type USD Million (2021-2026)
  • Table 188. India Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2021-2026)
  • Table 189. India Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 190. India Seborrheic Dermatitis Treatment, by Form Type USD Million (2021-2026)
  • Table 191. South Korea Seborrheic Dermatitis Treatment, by Type USD Million (2021-2026)
  • Table 192. South Korea Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2021-2026)
  • Table 193. South Korea Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 194. South Korea Seborrheic Dermatitis Treatment, by Form Type USD Million (2021-2026)
  • Table 195. Taiwan Seborrheic Dermatitis Treatment, by Type USD Million (2021-2026)
  • Table 196. Taiwan Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2021-2026)
  • Table 197. Taiwan Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 198. Taiwan Seborrheic Dermatitis Treatment, by Form Type USD Million (2021-2026)
  • Table 199. Australia Seborrheic Dermatitis Treatment, by Type USD Million (2021-2026)
  • Table 200. Australia Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2021-2026)
  • Table 201. Australia Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 202. Australia Seborrheic Dermatitis Treatment, by Form Type USD Million (2021-2026)
  • Table 203. Rest of Asia-Pacific Seborrheic Dermatitis Treatment, by Type USD Million (2021-2026)
  • Table 204. Rest of Asia-Pacific Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2021-2026)
  • Table 205. Rest of Asia-Pacific Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 206. Rest of Asia-Pacific Seborrheic Dermatitis Treatment, by Form Type USD Million (2021-2026)
  • Table 207. Europe Seborrheic Dermatitis Treatment, by Country USD Million (2021-2026)
  • Table 208. Europe Seborrheic Dermatitis Treatment, by Type USD Million (2021-2026)
  • Table 209. Europe Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2021-2026)
  • Table 210. Europe Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 211. Europe Seborrheic Dermatitis Treatment, by Form Type USD Million (2021-2026)
  • Table 212. Germany Seborrheic Dermatitis Treatment, by Type USD Million (2021-2026)
  • Table 213. Germany Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2021-2026)
  • Table 214. Germany Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 215. Germany Seborrheic Dermatitis Treatment, by Form Type USD Million (2021-2026)
  • Table 216. France Seborrheic Dermatitis Treatment, by Type USD Million (2021-2026)
  • Table 217. France Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2021-2026)
  • Table 218. France Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 219. France Seborrheic Dermatitis Treatment, by Form Type USD Million (2021-2026)
  • Table 220. Italy Seborrheic Dermatitis Treatment, by Type USD Million (2021-2026)
  • Table 221. Italy Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2021-2026)
  • Table 222. Italy Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 223. Italy Seborrheic Dermatitis Treatment, by Form Type USD Million (2021-2026)
  • Table 224. United Kingdom Seborrheic Dermatitis Treatment, by Type USD Million (2021-2026)
  • Table 225. United Kingdom Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2021-2026)
  • Table 226. United Kingdom Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 227. United Kingdom Seborrheic Dermatitis Treatment, by Form Type USD Million (2021-2026)
  • Table 228. Netherlands Seborrheic Dermatitis Treatment, by Type USD Million (2021-2026)
  • Table 229. Netherlands Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2021-2026)
  • Table 230. Netherlands Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 231. Netherlands Seborrheic Dermatitis Treatment, by Form Type USD Million (2021-2026)
  • Table 232. Rest of Europe Seborrheic Dermatitis Treatment, by Type USD Million (2021-2026)
  • Table 233. Rest of Europe Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2021-2026)
  • Table 234. Rest of Europe Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 235. Rest of Europe Seborrheic Dermatitis Treatment, by Form Type USD Million (2021-2026)
  • Table 236. MEA Seborrheic Dermatitis Treatment, by Country USD Million (2021-2026)
  • Table 237. MEA Seborrheic Dermatitis Treatment, by Type USD Million (2021-2026)
  • Table 238. MEA Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2021-2026)
  • Table 239. MEA Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 240. MEA Seborrheic Dermatitis Treatment, by Form Type USD Million (2021-2026)
  • Table 241. Middle East Seborrheic Dermatitis Treatment, by Type USD Million (2021-2026)
  • Table 242. Middle East Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2021-2026)
  • Table 243. Middle East Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 244. Middle East Seborrheic Dermatitis Treatment, by Form Type USD Million (2021-2026)
  • Table 245. Africa Seborrheic Dermatitis Treatment, by Type USD Million (2021-2026)
  • Table 246. Africa Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2021-2026)
  • Table 247. Africa Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 248. Africa Seborrheic Dermatitis Treatment, by Form Type USD Million (2021-2026)
  • Table 249. North America Seborrheic Dermatitis Treatment, by Country USD Million (2021-2026)
  • Table 250. North America Seborrheic Dermatitis Treatment, by Type USD Million (2021-2026)
  • Table 251. North America Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2021-2026)
  • Table 252. North America Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 253. North America Seborrheic Dermatitis Treatment, by Form Type USD Million (2021-2026)
  • Table 254. United States Seborrheic Dermatitis Treatment, by Type USD Million (2021-2026)
  • Table 255. United States Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2021-2026)
  • Table 256. United States Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 257. United States Seborrheic Dermatitis Treatment, by Form Type USD Million (2021-2026)
  • Table 258. Canada Seborrheic Dermatitis Treatment, by Type USD Million (2021-2026)
  • Table 259. Canada Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2021-2026)
  • Table 260. Canada Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 261. Canada Seborrheic Dermatitis Treatment, by Form Type USD Million (2021-2026)
  • Table 262. Mexico Seborrheic Dermatitis Treatment, by Type USD Million (2021-2026)
  • Table 263. Mexico Seborrheic Dermatitis Treatment, by Route of Administration USD Million (2021-2026)
  • Table 264. Mexico Seborrheic Dermatitis Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 265. Mexico Seborrheic Dermatitis Treatment, by Form Type USD Million (2021-2026)
  • Table 266. Research Programs/Design for This Report
  • Table 267. Key Data Information from Secondary Sources
  • Table 268. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Seborrheic Dermatitis Treatment: by Type USD Million (2015-2020)
  • Figure 5. Global Seborrheic Dermatitis Treatment: by Route of Administration USD Million (2015-2020)
  • Figure 6. Global Seborrheic Dermatitis Treatment: by Distribution Channel USD Million (2015-2020)
  • Figure 7. Global Seborrheic Dermatitis Treatment: by Form Type USD Million (2015-2020)
  • Figure 8. South America Seborrheic Dermatitis Treatment Share (%), by Country
  • Figure 9. Asia Pacific Seborrheic Dermatitis Treatment Share (%), by Country
  • Figure 10. Europe Seborrheic Dermatitis Treatment Share (%), by Country
  • Figure 11. MEA Seborrheic Dermatitis Treatment Share (%), by Country
  • Figure 12. North America Seborrheic Dermatitis Treatment Share (%), by Country
  • Figure 13. Global Seborrheic Dermatitis Treatment share by Players 2020 (%)
  • Figure 14. Global Seborrheic Dermatitis Treatment share by Players (Top 3) 2020(%)
  • Figure 15. Global Seborrheic Dermatitis Treatment share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Sonoma Pharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 18. Sonoma Pharmaceuticals (United States) Revenue: by Geography 2020
  • Figure 19. Merck (United States) Revenue, Net Income and Gross profit
  • Figure 20. Merck (United States) Revenue: by Geography 2020
  • Figure 21. Henkel (Germany) Revenue, Net Income and Gross profit
  • Figure 22. Henkel (Germany) Revenue: by Geography 2020
  • Figure 23. Arcutis Biotherapeutics (United States) Revenue, Net Income and Gross profit
  • Figure 24. Arcutis Biotherapeutics (United States) Revenue: by Geography 2020
  • Figure 25. Unilever (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 26. Unilever (United Kingdom) Revenue: by Geography 2020
  • Figure 27. Hikma Pharmaceuticals (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. Hikma Pharmaceuticals (United Kingdom) Revenue: by Geography 2020
  • Figure 29. Allen and Hanburys(United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. Allen and Hanburys(United Kingdom) Revenue: by Geography 2020
  • Figure 31. GlaxoSmithKline (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. GlaxoSmithKline (United Kingdom) Revenue: by Geography 2020
  • Figure 33. Bausch Health (Canada) Revenue, Net Income and Gross profit
  • Figure 34. Bausch Health (Canada) Revenue: by Geography 2020
  • Figure 35. Valent Pharmaceutical (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 36. Valent Pharmaceutical (United Kingdom) Revenue: by Geography 2020
  • Figure 37. West-Ward Pharmaceutical Corp. (United States) Revenue, Net Income and Gross profit
  • Figure 38. West-Ward Pharmaceutical Corp. (United States) Revenue: by Geography 2020
  • Figure 39. Global Seborrheic Dermatitis Treatment: by Type USD Million (2021-2026)
  • Figure 40. Global Seborrheic Dermatitis Treatment: by Route of Administration USD Million (2021-2026)
  • Figure 41. Global Seborrheic Dermatitis Treatment: by Distribution Channel USD Million (2021-2026)
  • Figure 42. Global Seborrheic Dermatitis Treatment: by Form Type USD Million (2021-2026)
  • Figure 43. South America Seborrheic Dermatitis Treatment Share (%), by Country
  • Figure 44. Asia Pacific Seborrheic Dermatitis Treatment Share (%), by Country
  • Figure 45. Europe Seborrheic Dermatitis Treatment Share (%), by Country
  • Figure 46. MEA Seborrheic Dermatitis Treatment Share (%), by Country
  • Figure 47. North America Seborrheic Dermatitis Treatment Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Sonoma Pharmaceuticals (United States)
  • Merck (United States)
  • Henkel (Germany)
  • Arcutis Biotherapeutics (United States)
  • Unilever (United Kingdom)
  • Hikma Pharmaceuticals (United Kingdom)
  • Allen and Hanburys(United Kingdom)
  • GlaxoSmithKline (United Kingdom)
  • Bausch Health (Canada)
  • Valent Pharmaceutical (United Kingdom)
  • West-Ward Pharmaceutical Corp. (United States)
Additional players considered in the study are as follows:
Summer Laboratories (United States) , Kramer laboratories (United States)
Select User Access Type

Key Highlights of Report


May 2021 200 Pages 82 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Seborrheic Dermatitis Treatment Quantitative research analysis
Global Seborrheic Dermatitis Treatment Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Seborrheic Dermatitis Treatment Report?

Have a Query? Click Here

Other Related Reports

Digestion Aids Comprehensive Study by Type (Probiotics, Digestive Enzymes, Fiber Supplements), Application (Food and Beverages, Supplements), Distribution Channel (Direct Sale (Offline, Online), Dis...
$ 3750
Paracetamol Comprehensive Study by Type (Tablets or Caplets, Capsules, Liquid), Application (Tablet Drug, Granules Drug, Oral Solution, Others), Raw Material (Phenol, Monochlorobenzene, Maize Starch,...
$ 3450
Topical Drug Delivery Comprehensive Study by Type (Skin Topical Drug Delivery , Ophthalmic Topical Drug Delivery , Rectal Topical Drug Delivery , Vaginal Topical Drug Delivery , Nasal Topical Drug De...
$ 3750
Pediatric Drugs Comprehensive Study by Type (Allergy and Respiratory Drugs, Anti-Infectives, Cancer Therapies, Cardiovascular Drugs, Central Nervous System Drugs, Gastrointestinal Drugs, Hormone Drug...
$ 3650
Soft Gelatin Capsules Comprehensive Study by Type (Gelatin, Non-Animal), Application (Pharmaceutical, Health Supplements, Others), Distribution Channel (Online, Offline), Outer Shell (Gelatin, Plasti...
$ 3350
Oral Thin Films Comprehensive Study by Type (Oromucosal, Orodispersible, • Orally Disintegrating, • Orally Dissolving), Application (Allergy/Cough and Cold, Pain Management, Anti-flatulence, Neurolog...
$ 3650